Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Chemotherapy for Incidental Gallbladder Cancer
NCT03579758Phase 3Withdrawn
- Sponsor
- Emory University
- Start
- Apr 2019
- Primary completion
- Jun 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, Cisplatin micelle injection (HA132) in gallbladder cancer, sponsored by Emory University. Planned start Apr 2019; status: withdrawn.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
gallbladder cancer
Beyond the preview
Go deeper on NCT03579758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579758.